An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...
New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.
Started by a patient, HealthTree lets blood cancer patients look for clinical trials and treatment options, share their data with researchers.
Study Progresses to Fourth Higher 90 mg/m2Dose CohortCompelling Patient Response Highlighted by Stable Disease and Significant Reduction in Blast ...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...
PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...
All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...
"Chris was the patient who made us forget how devastating this disease can be," said his doctors, calling him unforgettable.
100% of acute myeloid leukemia (AML) patients in both original ... enrollment of additional patients in its clinical trials, and advancement of clinical development plans; IN8bio’s ability ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results